Skip to content
Allen & Overy advises Dr. Max on the financing for the acquisition of Neo Apotek

Allen & Overy advises Dr. Max on the financing for the acquisition of Neo Apotek

News
12 January 2024
Related people
Sennhauser Stefano
Stefano Sennhauser

Partner

Milan
Image of Valentina Calo
Valentina Calò

Associate

Milan
Press contacts

For media enquiries relating to this topic, please contact:

Image of Cristina Canepone
Cristina Canepone

PR & Communications Manager

Milan

Headlines in this article

Related news and insights

News: 19 January 2024

Allen & Overy advises Aukera on a €450 million notes issuance facility with EIG

News: 18 January 2024

Allen & Overy advises Electra on its fundraising of EUR304 million to accelerate electric mobility in Europe

News: 11 January 2024

Allen & Overy advises lenders on the Damietta port project in Egypt

News: 22 December 2023

Allen & Overy advises Campari Group on its contemplated acquisition of premium Cognac Courvoisier, valuing Courvoisier at USD1.32 billion

Following the completion of the acquisition of Neo Apotek by Dr. Max Group, one of the most important operators specialising in the management of pharmacies in Europe, the agreements relating to the reimbursement, remodulation and provision of new finance in favour of Neo Apotek and some of its subsidiaries have been finalized.

Allen & Overy advised Dr. Max on the transaction in relation to all financial aspects preliminary and functional to the completion and implementation of the acquisition, including the repayment of part of the existing debt of NeoApotek and its subsidiaries, the remodeling of the remaining part and the obtaining of new finance for the group.

The A&O team was led by partner Stefano Sennhauser, supported by associate Valentina Calò and trainee Alessia Cellucci. 

Related expertise